[Federal Register Volume 78, Number 223 (Tuesday, November 19, 2013)]
[Notices]
[Page 69516]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27646]


=======================================================================
-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION


DeltaPoint Capital IV, L.P.; License No. 02/02-0662; Notice 
Seeking Exemption Under the Small Business Investment Act, Conflicts of 
Interest

    Notice is hereby given that DeltaPoint Capital IV, L.P., 45 East 
Avenue, 6th Floor, Rochester, NY 14604, Federal Licensee under the 
Small Business Investment Act of 1958, as amended (``the Act''), in 
connection with the financing of a small concern, has sought an 
exemption under Section 312 of the Act and Section 107.730, Financings 
which constitute conflicts of interest of the Small Business 
Administration (``SBA'') Rules and Regulations (13 CFR 107.730). 
DeltaPoint Capital IV, L.P. provided financing to BioMaxx, Inc., 1 
Fishers Road, Suite 160, Pittsford, NY 14534. The financing was 
contemplated for working capital purposes.
    The financing is brought within the purview of Sec.  107.730(a)(1) 
of the Regulations because DeltaPoint Capital IV (New York), L.P., an 
Associate of DeltaPoint Capital IV, L.P., owns more than ten percent of 
BioMaxx, Inc.
    Therefore, this transaction is considered a financing of an 
Associate requiring an exemption. Notice is hereby given that any 
interested person may submit written comments on the transaction within 
fifteen days of the date of this publication to the Associate 
Administrator for Investment and Innovation, U.S. Small Business 
Administration, 409 Third Street SW., Washington, DC 20416.

Javier E. Saade,
Associate Administrator for Investment & Innovation.
[FR Doc. 2013-27646 Filed 11-18-13; 8:45 am]
BILLING CODE P